ESOPs in India: The Complete Employee Stock Guide

Your offer letter says one of two things about equity. Either it stays vague — "ESOPs as per company policy" — or it lists a number so large it looks like a typo. Both tell you almost nothing. Employee stock ownership in India runs through a lifecycle that most people meet unprepared: a grant that feels like a gift, a vesting clock that quietly starts, an exercise decision that arrives with a tax bill, and a sale that may or may not ever be possible.

This guide is the map for the whole journey. The instrument zoo first — ESOP, RSU, ESPP, SAR and phantom equity, one crisp definition each. Then the lifecycle and the startup realities nobody puts in the offer letter, the listed-company version, the tax spine (our ESOP taxation guide works the arithmetic in full), the concentration-risk problem, and the rules that decide what happens to your equity the day you resign.

The instrument zoo: five things people call "ESOPs"

In Indian office conversation, every equity grant is "ESOPs". Legally and practically, these are different instruments, and the differences decide what you own, when, and what it costs you.

An ESOP — employee stock option — is an option in the strict sense: the right, not the obligation, to apply for shares at a predetermined price. The Income-tax Act, 2025 defines an option as "a right but not an obligation, granted to an employee to apply for the specified security or sweat equity shares at a predetermined price" (Section 17(4)(e)). You profit when the market value sits above your strike price; if it never does, the option expires worthless and you have lost nothing but the opportunity.

RSUs — restricted stock units — carry no strike price. The company promises to deliver shares (or their cash value) once conditions are met. Since there is nothing to pay, RSUs are simpler but taxed harder at delivery: the entire market value lands in your salary as a perquisite. Foreign-parent employers (Google India, Microsoft India, and the like) dominate this format, because the parent grants units over its overseas-listed stock.

ESPPs — employee stock purchase schemes — let you buy shares from your own salary, often at a discount, usually through a window twice a year. SEBI's framework treats an ESPS as a distinct scheme, with a minimum one-year lock-in on the shares allotted (Source: SEBI Share Based Employee Benefits and Sweat Equity Regulations, 2021, Regulation 22(2)).

SARs — stock appreciation rights — pay you the rise in share price above a base, in cash or shares, without you buying anything. SEBI's regulations define appreciation as the difference between market price on exercise or vesting and the SAR price, payable "in form of cash" or shares (Source: SEBI SBEB&S Regulations, 2021, definitions and Part C). Cash-settled SARs are pure salary with a variable trigger — you never become a shareholder.

Phantom equity is the informal cousin: a contractual cash bonus pegged to the value of shares you will never hold. Common in private companies that do not want the paperwork of issuing stock. It is not equity, not a security, and on payout it is simply salary.

The lifecycle: grant, vest, exercise, sell

Every real grant travels the same road. Learn the four stations and the jargon collapses.

Grant. The board approves and the company hands you an agreement: number of options, strike price, vesting schedule, exercise window, and the leaver terms. Under the Companies Act, 2013 framework for unlisted companies, the scheme needs shareholder approval by special resolution, and the explanatory statement must disclose the vesting requirements, the exercise price or its formula, the exercise period, lock-in, and the conditions under which vested options lapse (Source: Companies (Share Capital and Debentures) Rules, 2014, Rule 12(1) and 12(2)). If your grant letter does not state the post-resignation exercise window, ask before you sign — that single clause is worth more than most people's annual bonus.

Vesting. Options become yours on a schedule. The two standard shapes are the cliff — nothing vests until a date, commonly one year, then a block vests — and graded vesting, where a slice vests each quarter or year. The regulatory floor is one year between grant and vesting: the Companies Rules require a minimum period of one year between the grant of options and their vesting for unlisted companies (Rule 12(6)(a)), and SEBI's regulations impose the same minimum one-year vesting for listed-company schemes (Source: SEBI SBEB&S Regulations, 2021, Regulation 18(1)), with a waiver where the employee dies or suffers permanent incapacity.

Exercise. You pay the strike price and convert options into shares. This is where tax begins — the gap between the share's fair market value on exercise date and what you pay becomes taxable salary perquisite (see our ESOP taxation guide for the arithmetic and the startup deferral). Exercise is also the point of no return: once you hold shares, you carry their full downside, whereas an unexercised option's downside is capped at the strike you never paid.

Sale. For listed shares, you sell on the exchange the same day. For startup shares, you wait for a liquidity event — acquisition, IPO, or a buyback — because a private company's shares have no market. Unexercised options that sit past the exercise window lapse, and whatever you paid at grant or vesting may be forfeited (Source: SEBI SBEB&S Regulations, 2021, Regulation 20).

Startup ESOPs: the parts of the letter you should interrogate

Startup equity is where honest arithmetic matters most, because nothing can be checked against a market price.

The strike price is usually nominal. Unlisted companies have freedom to set the exercise price in line with their accounting policies (Source: Companies (Share Capital and Debentures) Rules, 2014, Rule 12(3)). Many Indian startups grant at or near face value — ₹10 a share is common — which means your real cost is not the strike but the tax bill at exercise, computed on the fair market value the tax rules assign. That tax FMV for an unlisted company is determined by a merchant banker under the valuation method prescribed for perquisites (Source: Income-tax Rules, 2026, Rule 15(6)(d)). It is a completely different number from the friendly price in your grant letter.

The offer says "options worth ₹80 lakh". The only honest question is: at what valuation, at what strike, taxed on what FMV, and sellable when?

Valuation reports are the Indian 409A. American readers will know the 409A appraisal that sets a private company's option strike. India's equivalent discipline arrives through the tax law: the company needs a defensible fair market value — merchant-banker or registered-valuer reports — both for accounting share-based payments and for the perquisite FMV your employer must report. When a startup quotes you a valuation, ask which report it comes from and how old it is.

Dilution and liquidation preference decide what your stake is worth. Two facts every employee should internalise. First, your percentage shrinks: every funding round mints new shares, and companies typically refresh the ESOP pool before a round, so your 0.5% at joining can be 0.3% by the exit — the absolute value can still grow, but only if the valuation grows faster than the share count. Second, preferences come before you: preferred investors commonly negotiate the right to recover their investment (often one times their money, sometimes with a multiple) ahead of common shareholders, which includes every ESOP share. On a modest exit, the preference stack can consume most of the proceeds. A ₹100 crore acquisition where investors hold ₹90 crore of preference does not make option holders rich. None of this is a scam — it is the standard structure — but it is the difference between paper wealth and a bank credit.

Founders and big shareholders normally cannot hold ESOPs — with a startup exception. The Companies Rules exclude promoters, promoter-group members, and directors holding more than 10% of the equity from ESOP eligibility — but waive both exclusions for a DPIIT-recognised startup for up to five years from incorporation (Source: Companies (Share Capital and Debentures) Rules, 2014, Rule 12(1) and the proviso introduced for startups). Sweat equity, priced through a registered valuer, is the usual alternative route for founders (Source: Rule 8(6) of the same Rules).

Listed-company plans: the RSU vest you barely notice

At listed companies — the IT majors, ITC, the banks — share-based pay arrives with far less drama, and that is precisely the trap. Vesting is automated: twice a year or so, RSUs or vested shares land in your demat account, the perquisite value silently joins your salary income, the employer deducts TDS, and shares appear that many employees never sell and rarely check.

The scale is real. These are the schemes SEBI's Share Based Employee Benefits and Sweat Equity Regulations, 2021 govern — mandatory minimum one-year vesting, prescribed accounting and disclosures, one-year lock-in on shares issued under a purchase scheme (Source: SEBI SBEB&S Regulations, 2021, Regulations 18 and 22). Companies must disclose scheme details and employee-wise grants in their annual reports, so you can see exactly how many options your organisation issues each year.

Three habits make the difference here. Check the vesting calendar in January and plan tax in advance, because several vests landing in one financial year can push you into a higher slab. Decide a standing rule for vests — for instance, sell a fixed share immediately and keep the rest by policy, not by mood. And reconcile the perquisite in Form 16 against the shares actually credited; mismatches happen more often than you would think.

The tax spine, in one section

Two tax moments, always in this order. First, at exercise or allotment: the gap between fair market value and what you pay is a salary perquisite, taxed at your slab rate with TDS deducted by the employer (Source: Income-tax Act, 2025, Section 17(1)(d) read with Section 17(4)(h) and Section 392(1)). Second, at sale: gains over that FMV are capital gains — for STT-paid listed shares, 20% short-term within twelve months and 12.5% long-term beyond, with the first ₹1.25 lakh of long-term gains exempt; for unlisted shares, long-term only after 24 months, at 12.5% (Source: Income-tax Act, 2025, Sections 196, 198 and 197; holding periods per the Income Tax Department's capital gains guidance). The cost basis for those gains is the FMV you were already taxed on at exercise (Section 73 of the same Act) — you are not taxed twice on the same slice.

Employees of eligible startups get one genuine relief: tax on the exercise perquisite can be deferred up to sixty months, or until sale or exit from the company, whichever comes first (Source: Income-tax Act, 2025, Section 289(3)). It is the single most valuable clause in startup equity — our ESOP taxation guide covers eligibility and mechanics.

Concentration risk: one employer holding your salary and your savings

Here is the structural problem with employee equity, stated plainly: it ties your income, your savings and your professional identity to a single company's fate. Your salary already makes you the single most exposed creditor your employer has. Adding a large equity stake means a company that stumbles takes your job and your portfolio in the same quarter.

Enron is the standard cautionary tale for a reason. When the company collapsed in 2001, employees who had loaded retirement savings with Enron stock — while their salaries and careers were already Enron-dependent — lost both at once. Nothing about the Indian market prevents the same pattern: a startup that fails takes its options to zero and its payroll with them; a listed employer in a multi-year drawdown does the same thing slowly.

The workable discipline is a cap. Many practitioners suggest treating any single employer's stock as a bounded slice of your investable portfolio — a common ceiling is 10% — and selling vested shares down to that line on a schedule. Selling vested shares is not disloyalty; the equity was compensation, and compensation is meant to be banked. What you must not do is sell and stay invested in the same story through some other instrument while calling it diversification.

Leaving the job: leaver clauses and exercise windows

Everything about exit depends on your plan document, and plan documents differ. The regulations require companies to disclose in advance the conditions under which options lapse, and the time window within which vested options must be exercised after termination or resignation (Source: SEBI SBEB&S Regulations, 2021; Companies (Share Capital and Debentures) Rules, 2014, Rule 12(2)(k) and (l)) — but the actual lengths are plan-specific, not fixed by law.

What that means in practice, and the questions to answer before you resign:

• Good leaver vs bad leaver. Most plans are generous on death, disability and redundancy, and harsh on resignation-for-cause or termination for misconduct — vested options can lapse entirely for misconduct.
• The post-employment exercise window. Plans set this themselves, and it is often far shorter than the runway you had while employed — practitioner guides note that leavers frequently face compressed deadlines, and unexercised vested options simply lapse (terms are plan-specific; your plan document is the only binding source). Exercising inside that window means paying the strike and the perquisite tax before any liquidity exists.
• Notice and garden leave. Some plans treat the garden-leave period as employment; others start the countdown at the last working day. The difference is months of exercise runway.
• Unvested grants die. Standard, near-universal, and worth remembering when you weigh a resignation against a vest date next quarter.
• Funded exercise. If the window is short and the strike is high, ask about cashless or funded exercise through the company's partner — availability varies and terms deserve scrutiny.

Your checklist at each stage

1. At grant: read the leaver clause and exercise window first; note the strike, the vesting schedule and the clause on what happens to vested options after you leave; file the agreement somewhere you will find it in five years.
2. At each vest: update a simple spreadsheet — vested count, strike, latest FMV; check whether the company refreshed the pool or issued new shares (dilution is visible in filings for listed companies and in cap-table updates for startups).
3. Before exercise: get the perquisite tax estimate in writing; for startups, confirm the deferral eligibility and what triggers repayment; decide exercise size against your liquidity, not your optimism.
4. At sale: apply the concentration cap, mind the twelve-month and twenty-four-month holding lines for capital gains, and route the proceeds into boring, diversified assets — our mutual funds guide is the natural next stop.
5. At exit: send HR a written query on your exercise deadline; set a personal reminder; do not let a vested grant lapse by calendar neglect.

Where to go next

The tax arithmetic — perquisite valuation, the sixty-month startup deferral, capital gains on listed and unlisted shares, the foreign-RSU conversion mechanics — is worked example by example in our ESOP taxation guide. When the selling starts, our ITR filing guide covers the capital-gains reporting that follows. And if the exercise decision is crowding out everything else, start with the basics: an emergency fund first, equity second — the same order that applies to every other investment.

This guide is educational, not investment or tax advice. Scheme terms vary by company; your plan document and a qualified advisor should arbitrate anything you act on.